ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
With the threat of drug-resistant tuberculosis growing, a group of more than 20 philanthropists has given $20 million to help scientists from the Broad Institute of MIT & Harvard unravel the mechanisms bacteria use to become resistant to antibiotics and develop rapid diagnostics for drug-resistant TB. The Broad team also hopes to translate its biological findings into fast-acting drugs. Currently, it can take up to six months of treatment to fully tackle TB. More than 2 billion people are infected with TB, and nearly 2 million of them die every year, Broad notes.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter